Beta-Lactams Flashcards
1
Q
What are the beta lactams
A
penicillins, cephalosporins, carbapenems, monobactams
2
Q
Chemical structure of penicillins
A
- All penicillins share the same basic structure of a 5-membered thiazolidine ring connected to a beta-lactam ring. The side chains differ among the penicillins, providing different antibacterial spectrums and PK properties, as well as greater beta-lactamase stability.
3
Q
Chemical structure of cephalosporins
A
- Cephalosporins contain a beta-lactam ring where the 5-membered thiazolidine ring of the penicillins is replaced by a 6-membered dihydrothiazine ring. This structural difference provides stability against some beta-lactamase enzymes that may render the penicillins inactive.
- Cephamycins are cephalosporins with a methoxy group at position 7 of the beta-lactam ring, which confers activity against anaerobes such as Bacteroides spp.
4
Q
Chemical structure of carbapenems
A
- Carbapenems are beta-lactam antibiotics with a carbapenem nucleus. Contain a beta-lactam ring fused to a 5-memebered ring, like the penicillins, but the 5-memebered ring of the carbapenem contains a carbon atom at position one instead of a sulfur atom. All contain a hydroxyethyl group in the trans configuration at position 6 as compared to an acylamino group in the cis configuration of the penicillins and cephalosporins. This results in increased antibacterial activity and greater stability against most beta-lactamase enzymes.
5
Q
Chemical structure of monobactams
A
- Monobactam: synthetic monocyclic beta-lactam antibiotics, only contains a beta-lactam ring with side chains.
6
Q
Beta-lactam mechanism of action
A
- Same mechanism of action: inhibitors of cell wall synthesis – interfere with bacterial cell wall synthesis by binding to and inhibiting enzymes called penicillin binding-proteins (PBPs) which are located in the cell wall of bacteria and are primarily expressed during cell division. Inhibit cross-linking of the cell wall. Inhibition of PBPs by beta-lactam antibiotics leads to inhibition of the final transpeptidation step of peptidoglycan synthesis, exposing a less osmotically stable cell membrane that leads to decreased bacterial growth, bacterial cell lysis, and death.
7
Q
Beta-lactam mechanisms of resistance
A
- destruction by beta-lactamase enzymes – hydrolyzes the cyclic amide bond of the beta-lactam ring, inactivating the antibiotic’ beta-lactamase enzymes produced by gram-negative bacteria reside in the periplasmic space, making it a very efficient mechanism of resistance.
- Cephalosporins are resistant to degradation by beta-lactamases of some bacteria.
- Inducible beta-lactamases: bacteria product beta-lactamase enzymes when exposed to antibiotics (such as during treatment of Enterobacter spp. Infections with ceftazidime).
- alteration in penicillin binding proteins (PBPs) – decreased binding affinity of penicillin to PBPs ex. MRSA, PRSP
- decreased permeability of outer cell membrane in gram-negative bacteria – altered porin proteins
8
Q
Pharmacodynamic properties of beta-lactams
A
display time-dependent (T>MIC) bactericidal activity (except enterococcus spp)
9
Q
Elimination half-life of beta-lactams
A
- Short elimination half-life (<2 hrs): repeated, frequent dosing is needed for most beta-lactams to maintain serum concentrations above the MIC of the infecting bacteria for an adequate amount of time (except ceftriaxone, cefotetan, cefixime, ertapenem)
10
Q
Route of elimination of beta-lactams
A
- Renal elimination: primarily eliminated unchanged by glomerular filtration and tubular secretion (except nafcillin, oxacillin, ceftriaxone, cefoperazone)
11
Q
Potential for cross-allergenicty of beta-lactams
A
- Cross-allergenicity: all except aztreonam